Literature DB >> 19729530

A new pet for myeloma.

Meletios-Athanassios Dimopoulos1, Lia A Moulopoulos, Evangelos Terpos.   

Abstract

In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.

Entities:  

Year:  2009        PMID： 19729530     DOI： 10.1182/blood-2009-06-224196

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  3 in total

1.  Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Teresa S Miceli; Kathleen Colson; Beth M Faiman; Kena Miller; Joseph D Tariman
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

Review 2.  Development of early treatment strategies for high-risk myeloma precursor disease in the future.

Authors:  Ola Landgren; S Vincent Rajkumar
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

Review 3.  Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.

Authors:  Adam J Waxman; Michael Kuehl; Arun Balakumaran; Brendan Weiss; Ola Landgren
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.